Mid-Market: S&P/ASX 200 Sharply Lower By 0.86%; 10 Out Of 11 Sectors Are Trading In Red Zone

On 29 December 2022, at AEDT 11:30 AM, the benchmark index S&P/ASX 200 is trading lower today, declining 60.80 points or 0.86%, and is currently trading at 7,025.60 levels. Out of 11 sectors, 10 sectors are trading lower along with the S&P/ASX 200.

The Healthcare sector is the only gaining sector, gaining 0.33% in its index value. On the other hand, the Energy and A-REIT sectors are the top 2 losing sectors, declining 2.25% and 1.84% in their index values.

Sayona Mining Limited (ASX: SYA) and Imugene Limited (ASX: IMU) are the top-gaining stocks, gaining 10.294% and 3.703% in their stock prices. On the other hand, Centuria Capital Group (ASX: CNI) and Dexus (ASX: DXS) are the top-losing stocks and are declining by 3.978% and 3.598% in their stock prices.

Factors influencing the market-

• Australian share market is declining in early trade, tracking a fall on Wall Street, as hopes for a year-end rally faded with renewed concerns about global growth.
• U.S. crude oil prices settled lower, as surging COVID-19 cases in China cast a shadow over the demand outlook amid Beijing's recent to move ease pandemic restrictions.
• Novonix Limited’s share price surged 4% to $1.45 after suffering a sharp drop in the previous session on talks Tesla was planning to temporarily halt production at its China factory.
• Dow has closed down by 1.10%, S&P 500 down by 1.20%, and NASDAQ ended lower by 1.35%.
• Hang Seng is up by 1.56%, and FTSE 100 is up by 0.32%.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com